FDA Adverse Event
Malfunction
Summary report: N
OMNIPOD INSULIN MANAGEMENT SYSTEM
MDR report key: 13681537
·
Received March 7, 2022
Report
- Report Number
- 3004464228-2022-03814
- Event Type
- Malfunction
- Date Received
- March 7, 2022
- Date of Event
- December 5, 2021
- Report Date
- December 5, 2021
- Manufacturer
- INSULET CORPORATION
- Product Code
- LZG
- UDI-DI
- 20385081120033
- PMA / PMN Number
- K192659
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 0
NO ALARMS, TIMEOUTS, NOR DRIVE STALLS WERE OBSERVED IN THE DATA. THE SOFT CANNULA WAS OBSERVED TO BE DAMAGED. IT COULD NOT BE DETERMINED WHEN THIS DAMAGE OCCURRED, NOR IF THIS DAMAGE RESULTED IN A FAILURE TO DELIVER INSULIN. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.
Description of Event or Problem · 0
IT WAS REPORTED THE PATIENTS BLOOD GLUCOSE LEVEL ROSE TO OVER 500 MG/DL WHILE WEARING THE POD BETWEEN 4 AND 24 HOURS ON THE ABDOMEN. AS TREATMENT, A MEW POD WAS PLACED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1963564 | OMNIPOD INSULIN MANAGEMENT SYSTEM | PUMP, INFUSION, INSULIN | LZG | INSULET CORPORATION | 19191 | L46125 | 20385081120033 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 15 YR | Male |